Cayetano von Kobbe

Years Active: 2023-2023
Publications (10 Years): 3

This page only lists publications with an associated author ORCID identifier.

Publications

Andrés Pastor-Fernández, Antonio R Bertos, Arantzazu Sierra-Ramírez, Javier Del Moral-Salmoral, Javier Merino, Ana I de Ávila, Cristina Olagüe, Ricardo Villares, Gloria González-Aseguinolaza, María Ángeles Rodríguez, Manuel Fresno, Nuria Gironés, Matilde Bustos, Cristian Smerdou, Pablo Jose Fernandez-Marcos, Cayetano von Kobbe
Treatment with the senolytics dasatinib/quercetin reduces SARS-CoV-2-related mortality in mice. Aging cell (2023)
Andrés Pastor-Fernández, Antonio R Bertos, Arantzazu Sierra-Ramírez, Javier Del Moral-Salmoral, Javier Merino, Ana I de Ávila, Cristina Olagüe, Ricardo Villares, Gloria González-Aseguinolaza, María Ángeles Rodríguez, Manuel Fresno, Nuria Gironés, Matilde Bustos, Cristian Smerdou, Pablo Jose Fernandez-Marcos, Cayetano von Kobbe
Treatment with the senolytics dasatinib/quercetin reduces SARS-CoV-2-related mortality in mice. Aging cell 22 (3) (2023)
Andrés Pastor-Fernández, Antonio R Bertos, Arantzazu Sierra-Ramírez, Javier Del Moral-Salmoral, Javier Merino, Ana I de Ávila, Cristina Olagüe, Ricardo Villares, Gloria González-Aseguinolaza, María Ángeles Rodríguez, Manuel Fresno, Nuria Gironés, Matilde Bustos, Cristian Smerdou, Pablo Jose Fernandez-Marcos, Cayetano von Kobbe
Treatment with the senolytics dasatinib/quercetin reduces SARS-CoV-2-related mortality in mice. Aging cell 22 (3) (2023)

Cayetano von Kobbe.css-eqlu8i{font-size:small;padding-left:4px;}